Skip to main content
. Author manuscript; available in PMC: 2019 May 22.
Published in final edited form as: Circulation. 2019 Mar 26;139(13):e579–e602. doi: 10.1161/CIR.0000000000000641

Reviewer Disclosures

Reviewer Employment Research Grant Other Research Support Speakers’ Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other
Geoffrey D. Barnes University of Michigan BMS/Pfizer None None None None BMS/Pfizer*; Jansen* None
Michael Fradley University of South Florida None None None None None Novartis* None
Eric H. Yang University of California at Los Angeles None None None None None Voluntis* None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*

Modest.

Significant.